The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data.
about
Advancements in MR imaging of the prostate: from diagnosis to interventionsBolus arrival time and its effect on tissue characterization with dynamic contrast-enhanced magnetic resonance imaging.Comparison of linear and nonlinear implementation of the compartmental tissue uptake model for dynamic contrast-enhanced MRIComparison of dynamic contrast-enhanced MRI and quantitative SPECT in a rat glioma model.Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challengeTemporal/spatial resolution improvement of in vivo DCE-MRI with compressed sensing-optimized FLASHReview of treatment assessment using DCE-MRI in breast cancer radiation therapy.Can DCE-MRI explain the heterogeneity in radiopeptide uptake imaged by SPECT in a pancreatic neuroendocrine tumor model?A feasible high spatiotemporal resolution breast DCE-MRI protocol for clinical settingsHigh-temporospatial-resolution dynamic contrast-enhanced (DCE) wrist MRI with variable-density pseudo-random circular Cartesian undersampling (CIRCUS) acquisition: evaluation of perfusion in rheumatoid arthritis patients.A reference agent model for DCE MRI can be used to quantify the relative vascular permeability of two MRI contrast agents.Role of high-field MR in studies of localized prostate cancer.Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.Dynamic contrast-enhanced MRI of the prostate: An intraindividual assessment of the effect of temporal resolution on qualitative detection and quantitative analysis of histopathologically proven prostate cancer.Accelerated Brain DCE-MRI Using Iterative Reconstruction With Total Generalized Variation Penalty for Quantitative Pharmacokinetic Analysis: A Feasibility Study.Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations.Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques.Dynamic contrast enhanced-MRI in rectal cancer: Inter- and intraobserver reproducibility and the effect of slice selection on pharmacokinetic analysis.Monitoring anti-angiogenic therapy in colorectal cancer murine model using dynamic contrast-enhanced MRI: comparing pixel-by-pixel with region of interest analysis.TumourMetrics: a comprehensive clinical solution for the standardization of DCE-MRI analysis in research and routine use.Linearization improves the repeatability of quantitative dynamic contrast-enhanced MRI.Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology.Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy.An efficient calculation method for pharmacokinetic parameters in brain permeability study using dynamic contrast-enhanced MRI.Evaluation of dynamic contrast-enhanced MRI derived microvascular permeability in recurrent glioblastoma treated with bevacizumab.
P2860
Q24594047-2DF2EDF2-CCCB-444F-8ED1-44CE652E4509Q30353922-CCEF9439-BE0E-43A1-B1BC-3EE21BF6DAF5Q30489816-4741B4B9-3786-4EF5-8AC5-8D1C955A2EC4Q30568292-95071DEC-ABD7-463E-8283-F4670EE96C4FQ30810438-6B796104-4A94-4DE3-9423-114D87752323Q34215586-DA20C02E-1E49-41AE-8392-9F8458E3118AQ34367593-CA26F9BA-DC7A-4483-8A68-CA2C14714606Q35015049-E964714C-ABE5-43D2-933D-2644ACD73461Q36303760-6B84CFB0-448C-437C-9D5F-66B343212A88Q36494614-602E7EB8-0DE7-401C-AFB7-E7BAC957BE3EQ37039971-87819915-D771-4E6E-8648-8C42F5FE8EC5Q38109111-BF816D0F-2B2E-4E1C-9C57-A8A5D768D5A0Q38829439-2BDBA737-4B29-41E1-81A8-79345E32337BQ38959728-F159A297-6F77-4C4A-A090-24B262EA74BFQ39742586-B4C5EC01-5389-40A3-96B4-62BB005A4B4AQ40917724-23977303-8B08-4F80-B021-4D8B0E4B3698Q41331956-3FDDF8EC-A769-46AB-966A-14AAE5AA071CQ41839877-9C709DC6-8C94-49F3-898B-1C44B7AF55EBQ46017323-C22269DD-1263-4382-8571-3426EEB89B60Q46180217-772C9A63-55CD-4A27-8A7E-785BEB589745Q47104951-AA94EAE7-6A64-4FCA-97E2-9F0DBE179559Q47332679-F6C093DE-2BC4-4547-80BC-177F98312DB6Q47948941-7AE13944-A752-4E64-9823-444F102A8F7FQ48141719-C9480107-131B-4A70-95A2-F68DBEBC638AQ48256960-69571809-8E56-413D-857B-3FCC77E10669Q48469860-0ACD3DD4-547A-449E-AD26-C8A141913611
P2860
The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The influence of temporal reso ...... parameters from DCE-MRI data.
@ast
The influence of temporal reso ...... parameters from DCE-MRI data.
@en
The influence of temporal reso ...... parameters from DCE-MRI data.
@nl
type
label
The influence of temporal reso ...... parameters from DCE-MRI data.
@ast
The influence of temporal reso ...... parameters from DCE-MRI data.
@en
The influence of temporal reso ...... parameters from DCE-MRI data.
@nl
prefLabel
The influence of temporal reso ...... parameters from DCE-MRI data.
@ast
The influence of temporal reso ...... parameters from DCE-MRI data.
@en
The influence of temporal reso ...... parameters from DCE-MRI data.
@nl
P2093
P2860
P356
P1476
The influence of temporal reso ...... parameters from DCE-MRI data.
@en
P2093
Bart M ter Haar Romeny
Gregory S Karczmar
Johannes Buurman
Marieke Heisen
Natal A W van Riel
Xiaobing Fan
P2860
P304
P356
10.1002/MRM.22171
P577
2010-03-01T00:00:00Z